Does Virginia Medicaid cover Wegovy for Heart Disease Risk Reduction?
Yes. Virginia Medicaid covers Wegovy for heart disease risk reduction with prior authorization. Other policy requirements and your plan's benefits also apply.
Full requirements: Wegovy for Heart Disease Risk Reduction (1 plan type)›
Applies to Medicaid plans.
Covered with requirements
What you need to qualify
Established cardiovascular disease
Documentation to bring
GLP-1 Receptor Agonist For Cardiovascular Risk Reduction in Members with Obesity or Overweight SA Form
Policy note: The document references a separate SA form titled 'GLP-1 Receptor Agonist For Cardiovascular Risk Reduction in Members with Obesity or Overweight SA Form'. The indication is identified as cardiovascular risk reduction in members with obesity or overweight. Detailed clinical criteria are contained in the referenced fax form, not reproduced here. The document notes 'The selected GLP-1 Receptor Agonist is injectable brand Wegovy' for this indication. Authorization length is 'as indicated on fax form'.
Policy effective April 1, 2026 · verified June 4, 2026 · source: V Amed Pdl List Criteria 20260401 V6
· View policy document (PDF)
Yes. Virginia Medicaid covers Wegovy for heart disease risk reduction with prior authorization. Other policy requirements and your plan's benefits also apply.
How current is this information?
The oldest review date among the policies on this page is June 4, 2026. Each policy's effective and verification dates appear with its requirements. Confirm current benefits with your plan.
Card and program names on file in Virginia
These names map to Virginia Medicaid, including older names and spelling variants. This is not a list of plans currently accepting members.